Effectiveness of Damoctocog Alfa Pegol to Treat Patients With Hemophilia A Enrolled in the <scp>ATHNdataset</scp>
A low number of bleeds were observed with damoctocog alfa pegol in the real world in both male and female PLwHA. Data should be interpreted with caution owing to limitations of real-world studies and insubstantial data for female PLwHA.
Authors
- Michael Recht (ORCID: https://orcid.org/0000-0002-2805-1016)
- Martin Chandler (ORCID: https://orcid.org/0000-0002-0921-5046)
- Jessica Charlet
- Thomas Moulton
- Lena Charafi
Institutions
- Bayer (United States) (US)
- Yale University (US)
- American Thrombosis and Hemostasis Network (US)
Publication Details
- Journal
- European Journal Of Haematology
- Published
- 2024-11-18
- DOI
- https://doi.org/10.1111/ejh.14337
- Citations
- 1
- Primary Topic
- Hemophilia Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.45
Funders
- Bayer